Future Science Group
Browse
Supplementary materials.xlsx (485.38 kB)

Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A - Supplementary materials.xlsx

Download (485.38 kB)
dataset
posted on 2022-05-10, 09:59 authored by Arash Mahajerin, Imi Faghmous, Peter Kuebler, Monet Howard, Tao XU, Carlos Flores, Tiffany Chang, Francis Nissen

Channeling effects in the prescription of new therapies - the case of emicizumab for hemophilia A: Supporting information


Supplementary Table 1: Code listings


Funding

F. Hoffmann-La Roche, (Grant / Award Number: )

History

Usage metrics

    Journal of Comparative Effectiveness Research

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC